Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 79 articles:
HTML format
Text format



Single Articles


    November 2017
  1. XUE X, Fei X, Hou W, Zhang Y, et al
    miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer.
    Cancer Lett. 2017;412:170-178.
    PubMed     Text format     Abstract available


  2. JING L, Song F, Liu Z, Li J, et al
    MLKL-PITPalpha signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.
    Cancer Lett. 2017 Nov 2. pii: S0304-3835(17)30693.
    PubMed     Text format     Abstract available


    October 2017
  3. LIU X, Chen B, You W, Xue S, et al
    The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 23. pii: S0304-3835(17)30652.
    PubMed     Text format     Abstract available


  4. LE HT, Nguyen HT, Min HY, Hyun SY, et al
    Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells.
    Cancer Lett. 2017 Oct 20. pii: S0304-3835(17)30648.
    PubMed     Text format     Abstract available


  5. LI X, Ma T, Zhang Q, Chen YG, et al
    Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population.
    Cancer Lett. 2017;406:22-26.
    PubMed     Text format     Abstract available


  6. TANG ZH, Cao WX, Guo X, Dai XY, et al
    Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
    Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30624.
    PubMed     Text format     Abstract available


  7. TORRES-DURAN M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, et al
    Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30603.
    PubMed     Text format     Abstract available


  8. YANG H, Lee MH, Park I, Jeon H, et al
    HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
    Cancer Lett. 2017;411:19-26.
    PubMed     Text format     Abstract available


  9. BETTI M, Casalone E, Ferrante D, Aspesi A, et al
    Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
    Cancer Lett. 2017;405:38-45.
    PubMed     Text format     Abstract available


    September 2017
  10. KIM SJ, Jung KH, Son MK, Park JH, et al
    Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.
    Cancer Lett. 2017;403:339-353.
    PubMed     Text format     Abstract available


  11. CHAN KK, Leung CO, Wong CC, Ho DW, et al
    Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.
    Cancer Lett. 2017;403:330-338.
    PubMed     Text format     Abstract available


  12. CAO L, Qi L, Zhang L, Song W, et al
    Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ss signaling pathway in lung adenocarcinoma.
    Cancer Lett. 2017;403:246-259.
    PubMed     Text format     Abstract available


  13. LIU CH, Lan CT, Chou JF, Tseng TJ, et al
    CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
    Cancer Lett. 2017;403:280-288.
    PubMed     Text format     Abstract available


  14. LIANG Z, Cheng Y, Chen Y, Hu Y, et al
    EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs.
    Cancer Lett. 2017;403:186-194.
    PubMed     Text format     Abstract available


  15. WANG C, Zhou X, Li W, Li M, et al
    Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Cancer Lett. 2017;403:271-279.
    PubMed     Text format     Abstract available


  16. ZHOU J, Zhang S, Chen X, Zheng X, et al
    Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer.
    Cancer Lett. 2017 Sep 1. pii: S0304-3835(17)30518.
    PubMed     Text format     Abstract available


    August 2017
  17. BAI Z, Gao M, Zhang H, Guan Q, et al
    BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Cancer Lett. 2017;402:81-92.
    PubMed     Text format     Abstract available


  18. WANG ZQ, He CY, Hu L, Shi HP, et al
    Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
    Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
    PubMed     Text format     Abstract available


  19. ZHOU L, Lv T, Zhang Q, Zhu Q, et al
    The biology, function and clinical implications of exosomes in lung cancer.
    Cancer Lett. 2017 Aug 12. pii: S0304-3835(17)30480.
    PubMed     Text format     Abstract available


  20. PARK KS, Yang H, Choi J, Seo S, et al
    The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30464.
    PubMed     Text format     Abstract available


  21. PISANU ME, Noto A, De Vitis C, Morrone S, et al
    Blockade of Stearoyl-CoA-Desaturase 1 activity reverts resistance to Cisplatin in lung cancer stem cells.
    Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30463.
    PubMed     Text format     Abstract available


  22. LI J, Tian H, Pan J, Jiang N, et al
    Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer.
    Cancer Lett. 2017 Aug 5. pii: S0304-3835(17)30466.
    PubMed     Text format     Abstract available


  23. YANG D, Cao X, Wang F, Jiang H, et al
    LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
    Cancer Lett. 2017;400:137-148.
    PubMed     Text format     Abstract available


  24. WU J, He Z, Yang XM, Li KL, et al
    RCCD1 depletion attenuates TGF-beta-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
    Cancer Lett. 2017;400:18-29.
    PubMed     Text format     Abstract available


    July 2017
  25. TONG CWS, Wu WKK, Loong HHF, Cho WCS, et al
    Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer.
    Cancer Lett. 2017 Jul 31. pii: S0304-3835(17)30459.
    PubMed     Text format     Abstract available


  26. STAPELFELD C, Neumann KT, Maser E
    Different inhibitory potential of sex hormones on NNK detoxification in vitro: a possible explanation for gender-specific lung cancer risk.
    Cancer Lett. 2017 Jul 22. pii: S0304-3835(17)30451.
    PubMed     Text format     Abstract available


  27. MENG X, Liu Y, Zhang J, Teng F, et al
    PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges.
    Cancer Lett. 2017 Jul 6. pii: S0304-3835(17)30415.
    PubMed     Text format     Abstract available


  28. GORZALCZANY Y, Akiva E, Klein O, Merimsky O, et al
    Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
    Cancer Lett. 2017;397:23-32.
    PubMed     Text format     Abstract available


    June 2017
  29. BROCK M, Mei Y
    Protein functional effector sncRNAs (pfeRNAs) in lung cancer.
    Cancer Lett. 2017 Jun 19. pii: S0304-3835(17)30394.
    PubMed     Text format     Abstract available


  30. DENG M, Zeng C, Lu X, He X, et al
    miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
    PubMed     Text format     Abstract available


  31. CHANG TH, Tsai MF, Gow CH, Wu SG, et al
    Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Cancer Lett. 2017;402:190-202.
    PubMed     Text format     Abstract available


  32. CHANG YC, Chan YC, Chang WM, Lin YF, et al
    Feedback regulation of ALDOA activates the HIF-1alpha/MMP9 axis to promote lung cancer progression.
    Cancer Lett. 2017;403:28-36.
    PubMed     Text format     Abstract available


  33. KWON OS, Hong SK, Kwon SJ, Go YH, et al
    BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.
    Cancer Lett. 2017 Jun 10. pii: S0304-3835(17)30355.
    PubMed     Text format     Abstract available


  34. DONG X, Liao W, Zhang L, Tu X, et al
    RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Cancer Lett. 2017 Jun 6. pii: S0304-3835(17)30370.
    PubMed     Text format     Abstract available


  35. NERI S, Miyashita T, Hashimoto H, Suda Y, et al
    Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.
    Cancer Lett. 2017;395:20-30.
    PubMed     Text format     Abstract available


    May 2017
  36. SILVA PM, Ribeiro N, Lima RT, Andrade C, et al
    Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
    Cancer Lett. 2017;394:33-42.
    PubMed     Text format     Abstract available


  37. CHEN S, Dong Z, Yang P, Wang X, et al
    Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
    Cancer Lett. 2017;394:22-32.
    PubMed     Text format     Abstract available


  38. CASTANON E, Soltermann A, Lopez I, Roman M, et al
    The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
    Cancer Lett. 2017 May 24. pii: S0304-3835(17)30342.
    PubMed     Text format     Abstract available


  39. ZHANG J, Kong L, Jiao Q, Li M, et al
    Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead.
    Cancer Lett. 2017 May 16. pii: S0304-3835(17)30311.
    PubMed     Text format     Abstract available


    April 2017
  40. WANG Y, Zhou Y, Tao F, Chai S, et al
    N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
    Cancer Lett. 2017 Apr 26. pii: S0304-3835(17)30292.
    PubMed     Text format     Abstract available


    March 2017
  41. LI K, Mo C, Gong D, Chen Y, et al
    DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of beta-catenin.
    Cancer Lett. 2017 Mar 1. pii: S0304-3835(17)30146.
    PubMed     Text format     Abstract available


    February 2017
  42. LI Y, Sun N, Lu Z, Sun S, et al
    Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Cancer Lett. 2017 Feb 18. pii: S0304-3835(17)30125.
    PubMed     Text format     Abstract available


  43. WANG Y, Fu L, Cui M, Wang Y, et al
    Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1.
    Cancer Lett. 2017 Feb 12. pii: S0304-3835(17)30078.
    PubMed     Text format     Abstract available


  44. SHEN CJ, Chan SH, Lee CT, Huang WC, et al
    Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
    Cancer Lett. 2017;386:110-122.
    PubMed     Text format     Abstract available


    January 2017
  45. WANG J, Wang Y, Mei H, Yin Z, et al
    The BET Bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21.
    Cancer Lett. 2017 Jan 28. pii: S0304-3835(17)30072.
    PubMed     Text format     Abstract available


    December 2016
  46. LIN TS, Lee H, Chen RA, Ho ML, et al
    Corrigendum to "An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection" [Cancer Lett. 226 (1) (2005 Aug 8) 77-84].
    Cancer Lett. 2016 Dec 27. pii: S0304-3835(16)30788.
    PubMed     Text format    


    November 2016
  47. MOURONTE-ROIBAS C, Leiro-Fernandez V, Fernandez-Villar A, Botana-Rial M, et al
    COPD, emphysema and the onset of lung cancer. A systematic review.
    Cancer Lett. 2016;382:240-244.
    PubMed     Text format     Abstract available


  48. KIM JY, Lee N, Kim YJ, Cho Y, et al
    Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
    Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30710.
    PubMed     Text format     Abstract available


  49. ZYSK A, DeNichilo MO, Panagopoulos V, Zinonos I, et al
    Adoptive transfer of ex vivo expanded Vgamma9Vdelta2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.
    Cancer Lett. 2016 Nov 16. pii: S0304-3835(16)30699.
    PubMed     Text format     Abstract available


    August 2016
  50. CHEN H, Cong Q, Du Z, Liao W, et al
    Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Cancer Lett. 2016 Aug 26. pii: S0304-3835(16)30495.
    PubMed     Text format     Abstract available


  51. PARK SJ, Choi YS, Lee S, Lee YJ, et al
    BIX02189 inhibits TGF-beta1-induced lung cancer cell metastasis by directly targeting TGF-beta type I receptor.
    Cancer Lett. 2016;381:314-322.
    PubMed     Text format     Abstract available


    July 2016
  52. ONG PS, Wang L, Chia DM, Seah JY, et al
    A novel combinatorial strategy using Seliciclib(R) and Belinostat(R) for eradication of non-small cell lung cancer via apoptosis induction and BID activation.
    Cancer Lett. 2016 Jul 25. pii: S0304-3835(16)30440.
    PubMed     Text format     Abstract available


  53. YI C, Wang Y, Zhang C, Xuan Y, et al
    Cleavage and polyadenylation specific factor 4 targets NF-kappaB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Cancer Lett. 2016;381:1-13.
    PubMed     Text format     Abstract available


  54. SHI P, Oh YT, Zhang G, Yao W, et al
    Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
    Cancer Lett. 2016;380:494-504.
    PubMed     Text format     Abstract available


  55. KONG J, Sun W, Li C, Wan L, et al
    Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
    Cancer Lett. 2016;380:476-484.
    PubMed     Text format     Abstract available


  56. HONG SK, Park JR, Kwon OS, Kim KT, et al
    Induction of integrin beta3 by sustained ERK activity promotes the invasiveness of TGFbeta-induced mesenchymal tumor cells.
    Cancer Lett. 2016;376:339-46.
    PubMed     Text format     Abstract available


    June 2016
  57. HOU J, Wang T, Xie Q, Deng W, et al
    N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-kappaB/p65.
    Cancer Lett. 2016;376:22-33.
    PubMed     Text format     Abstract available


  58. LENG C, Zhang ZG, Chen WX, Luo HP, et al
    An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Cancer Lett. 2016;376:188-96.
    PubMed     Text format     Abstract available


  59. SHOU J, You L, Yao J, Xie J, et al
    Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
    Cancer Lett. 2016 Jun 2. pii: S0304-3835(16)30359.
    PubMed     Text format     Abstract available


  60. COTRONEO CE, Dassano A, Colombo F, Pettinicchio A, et al
    Expression quantitative trait analysis reveals fine germline transcript regulation in mouse lung tumors.
    Cancer Lett. 2016;375:221-30.
    PubMed     Text format     Abstract available


    May 2016
  61. LI Q, Liu Z, Xu M, Xue Y, et al
    PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.
    Cancer Lett. 2016;375:190-8.
    PubMed     Text format     Abstract available


  62. DUAN B, Cui J, Sun S, Zheng J, et al
    EGF-stimulated activation of Rab35 regulates RUSC2-GIT2 complex formation to stabilize GIT2 during directional lung cancer cell migration.
    Cancer Lett. 2016 May 26. pii: S0304-3835(16)30340.
    PubMed     Text format     Abstract available


  63. SZPECHCINSKI A, Rudzinski P, Kupis W, Langfort R, et al
    Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.
    Cancer Lett. 2016;374:202-7.
    PubMed     Text format     Abstract available


    April 2016
  64. LV YF, Dai H, Yan GN, Meng G, et al
    Downregulation of tumor suppressing STF cDNA 3 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3beta/beta-catenin/Snail signaling pathway.
    Cancer Lett. 2016;373:164-73.
    PubMed     Text format     Abstract available


  65. LEE CC, Yang WH, Li CH, Cheng YW, et al
    Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
    Cancer Lett. 2016 Apr 6. pii: S0304-3835(16)30213.
    PubMed     Text format     Abstract available


    March 2016
  66. LIN TY, Hsu HY
    Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation.
    Cancer Lett. 2016 Mar 15. pii: S0304-3835(16)30166.
    PubMed     Text format     Abstract available


  67. DEBEN C, Lardon F, Wouters A, Op de Beeck K, et al
    APR-246 (PRIMA-1) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines.
    Cancer Lett. 2016 Mar 11. pii: S0304-3835(16)30165.
    PubMed     Text format     Abstract available


  68. ZHANG Z, Xiaomei R, Xiaoyun L, Deping W, et al
    GZD856, a novel potent PDGFRalpha/beta inhibitor, suppresses the growth and migration of lung cancer cells in vitro and in vivo.
    Cancer Lett. 2016 Mar 1. pii: S0304-3835(16)30071.
    PubMed     Text format     Abstract available


    February 2016
  69. KAWPRASERTSRI S, Pietras RJ, Marguez-Garban DC, Boonyaratanakornkit V, et al
    Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.
    Cancer Lett. 2016 Feb 15. pii: S0304-3835(16)30068.
    PubMed     Text format     Abstract available


  70. MUNAGALA R, Aqil F, Jeyabalan J, Gupta RC, et al
    Bovine milk-derived exosomes for drug delivery.
    Cancer Lett. 2016;371:48-61.
    PubMed     Text format     Abstract available


    January 2016
  71. MACDONAGH L, Gray SG, Breen E, Cuffe S, et al
    Lung cancer stem cells: The root of resistance.
    Cancer Lett. 2016 Jan 18. pii: S0304-3835(16)00024.
    PubMed     Text format     Abstract available


  72. LIU Y, Luo F, Wang B, Li H, et al
    STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells.
    Cancer Lett. 2016;370:125-35.
    PubMed     Text format     Abstract available


    December 2015
  73. PARK KS, Oh B, Lee MH, Nam KY, et al
    The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.
    Cancer Lett. 2015 Dec 23. pii: S0304-3835(15)00766.
    PubMed     Text format     Abstract available


  74. KAUR G, Reinhart RA, Monks A, Evans D, et al
    Bromodomain and hedgehog pathway targets in small cell lung cancer.
    Cancer Lett. 2015 Dec 10. pii: S0304-3835(15)00737.
    PubMed     Text format     Abstract available


  75. GUO H, Liu S, Guo J, Li B, et al
    Rapid on-site evaluation during endobronchial ultrasound-guided transbronchial needle aspirates for the diagnosis of hilar and mediastinal lymphadenopathy in patients with lung cancer.
    Cancer Lett. 2015 Dec 4. pii: S0304-3835(15)00728.
    PubMed     Text format     Abstract available


  76. NIE W, Ge HJ, Yang XQ, Sun X, et al
    LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
    Cancer Lett. 2015 Dec 3. pii: S0304-3835(15)00700.
    PubMed     Text format     Abstract available


  77. DE AGUIAR RB, Parise CB, Souza CR, Braggion C, et al
    Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings.
    Cancer Lett. 2015 Dec 3. pii: S0304-3835(15)00720.
    PubMed     Text format     Abstract available


  78. SACHDEVA M, Dodd RD, Huang Z, Grenier C, et al
    Epigenetic silencing of Kruppel like factor-3 increases expression of pro-metastatic miR-182.
    Cancer Lett. 2015;369:202-11.
    PubMed     Text format     Abstract available


    November 2015
  79. XU S, Lou F, Wu Y, Sun DQ, et al
    Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients.
    Cancer Lett. 2015 Nov 12. pii: S0304-3835(15)00679.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: